Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interference
Launay, M., Guitton, J., Balluet, R., Moreau, A., Phelip, J.-M., Tholance, Y., Gonzalo, P.
Published in Annals of oncology (01.08.2022)
Published in Annals of oncology (01.08.2022)
Get full text
Journal Article
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer
Mineur, L, François, E, Plassot, C, Phelip, J M, Miglianico, L, Dourthe, L M, Bonichon, N, Moreau, L, Guimbaud, R, Smith, D, Achille, E, Hervé, R, Bons, J M, Remy, S, Faroux, R, Villing, A L, Mahamat, A, Rabbia, I, Soulié, P, Baumgaertner, I, Mathé, N, Vazquez, L, Boustany, R
Published in PloS one (21.12.2020)
Published in PloS one (21.12.2020)
Get full text
Journal Article
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course
Paul, S., Boschetti, G., Rinaudo-Gaujous, M., Moreau, A., Del Tedesco, E., Bonneau, J., Presles, E., Mounsef, F., Clavel, L., Genin, C., Flourié, B., Phelip, J-M., Nancey, S., Roblin, X.
Published in Journal of Crohn's and colitis (01.06.2015)
Published in Journal of Crohn's and colitis (01.06.2015)
Get full text
Journal Article
Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics
Lepage, C., Phelip, J.-M., Cany, L., Maillard, E., Lievre, A., Chatellier, T., Faroux, R., Duchmann, J.-C., Ben Abdelghani, M., Breysacher, G., Geoffroy, P., Pere-Verge, D., Pelaquier, A., Pillon, D., Ezenfis, J., Rinaldi, Y., Darut-Jouve, A., Duluc, M., Adenis, A., Bouché, O.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Drug interaction between infliximab and azathioprine in patients with Crohn's disease
Roblin, X., Serre‐Debeauvais, F., Phelip, J.‐M., Bessard, G., Bonaz, B.
Published in Alimentary pharmacology & therapeutics (01.11.2003)
Published in Alimentary pharmacology & therapeutics (01.11.2003)
Get full text
Journal Article
Colon cancer in France: evidence for improvement in management and survival
Faivre-Finn, C, Bouvier-Benhamiche, A-M, Phelip, J M, Manfredi, S, Dancourt, V, Faivre, J
Published in Gut (01.07.2002)
Published in Gut (01.07.2002)
Get full text
Journal Article
STATUS OF THE ASTRID CORE AT THE END OF THE PRE-CONCEPTUAL DESIGN PHASE 1
CHENAUD, MS, DEVICTOR, N., MIGNOT, G., VARAINE, F., VÉNARD, C., MARTIN, L., PHELIP, M., LORENZO, D., SERRE, F., BERTRAND, F., ALPY, N., LE FLEM, M., GAVOILLE, P., LAVASTRE, R., RICHARD, P., VERRIER, D., SCHMITT, D.
Published in Nuclear engineering and technology (01.11.2013)
Published in Nuclear engineering and technology (01.11.2013)
Get full text
Journal Article
6‐Tioguanine monitoring in steroid‐dependent patients with inflammatory bowel diseases receiving azathioprine
Roblin, X., Serre‐Debeauvais, F., Phelip, J.‐M., Faucheron, J.‐L., Hardy, G., Chartier, A., Helluwaert, F., Bessard, G., Bonaz, B.
Published in Alimentary pharmacology & therapeutics (01.04.2005)
Published in Alimentary pharmacology & therapeutics (01.04.2005)
Get full text
Journal Article
Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey
OUSSALAH, A., ROBLIN, X., LAHARIE, D., FILIPPI, J., FLAMANT, M., FAURE, P., PHELIP, J.‐M., BIGARD, M.‐A., PEYRIN‐BIROULET, L.
Published in Alimentary pharmacology & therapeutics (01.10.2009)
Published in Alimentary pharmacology & therapeutics (01.10.2009)
Get full text
Journal Article
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial
Roblin, X., Boschetti, G., Williet, N., Nancey, S., Marotte, H., Berger, A., Phelip, J. M., Peyrin‐Biroulet, L., Colombel, J. F., Del Tedesco, E., Paul, S., Flourie, B.
Published in Alimentary pharmacology & therapeutics (01.07.2017)
Published in Alimentary pharmacology & therapeutics (01.07.2017)
Get full text
Journal Article
Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study
Roblin, Xavier, Boschetti, Gilles, Duru, Gérard, Williet, Nicolas, Deltedesco, Emilie, Phelip, Jean M, Peyrin-Biroulet, Laurent, Nancey, Stéphane, Flourié, Bernard, Paul, Stéphane
Published in Inflammatory bowel diseases (01.11.2017)
Published in Inflammatory bowel diseases (01.11.2017)
Get full text
Journal Article
Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn’s disease
ROBLIN, X., PHELIP, J. M., GENEVOIS, M., DUCROS, V., BONAZ, B.
Published in Alimentary Pharmacology and Therapeutics (01.04.2007)
Published in Alimentary Pharmacology and Therapeutics (01.04.2007)
Get full text
Journal Article
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease
Roblin, X., Marotte, H., Leclerc, M., Del Tedesco, E., Phelip, J.M., Peyrin-Biroulet, L., Paul, S.
Published in Journal of Crohn's and colitis (01.07.2015)
Published in Journal of Crohn's and colitis (01.07.2015)
Get full text
Journal Article
Impact of diabetes mellitus on clinical presentation and prognosis of pancreatic cancer
Dehayem, Y.M, Phelip, J.-M, Kengne, A.-P, Choukem, S.-P, Benhamou, P.-Y, Halimi, S
Published in Annales d'endocrinologie (01.02.2011)
Published in Annales d'endocrinologie (01.02.2011)
Get full text
Journal Article
Exploratory analyses of 400 patients enrolled in 2 FFCD trials of first line treatment for metastatic pancreatic cancer
Taieb, J., Phelip, J.M., Rinaldi, Y., Barbier, E., Bouche, O., Khemissa Akouz, F., Gratet, A., Petorin, C., Miglianico, L., Malka, D., Laharie Mineur, H., Rebischung, C., Lepage, C., Francois, E., Dahan, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity
Roblin, Xavier, Peyrin-Biroulet, Laurent, Biroulet, Laurent P, Phelip, Jean M, Nancey, Stéphane, Flourie, Bernard
Published in The American journal of gastroenterology (01.12.2008)
Published in The American journal of gastroenterology (01.12.2008)
Get full text
Journal Article